Community Healthcare Trust Incorporated logo

Community Healthcare Trust Incorporated

CHCT

NYSEReal EstateREIT - Healthcare Facilities

Previous close

$14.87

$0.00 · 0.00%

Aug 21, 4:00 PM ET

Pre-market

$14.87

$0.00 · 0.00%

Aug 24, 6:03 AM ET

CHCT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jun 22, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

100

Deep Value

Momentum

50

Neutral

Sentiment

57

Mixed

Risk resilience

77

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.2 billion US dollars in 198 real estate properties (including one property with sales-type leases and one property classified as held for sale). The properties are in 36 states, totaling approximately 4.5 million square feet in the aggregate. Community Healthcare Trust Incorporated was incorporated in 2014 in Maryland, USA.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
David H. Dupuy
Listed since
May 21, 2015
Employees
35

Market position

Day range

Current $14.87

52-week range

Current $14.87

Open
$14.82
Previous close
$14.87
Volume
211.16K
0.88× average
Average volume
239.45K
Average daily volume
Market cap
424.86M USD
Beta
0.68
Market reference 1
50-day average
$17.3778
-14.43% below average
200-day average
$16.7744
-11.35% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
973.85M USD
P/E (TTM)
22.15×
P/B (TTM)
0.97×
P/S (TTM)
3.41×
EV / EBITDA
11.77×
Earnings yield
1.16%
Free cash flow yield
8.14%
Dividend yield
11.85%

Profitability & efficiency

Gross margin
63.21%
Operating margin
39.10%
Net margin
16.85%
Return on equity
1.19%
Return on assets
0.51%
Return on invested capital
2.08%

Financial health

Debt / equity
1.36×
Current ratio
0.17×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends92%57%23%-11%Gross margin, FY2021: 83.27%Gross margin, FY2022: 82.97%Gross margin, FY2023: 81.64%Gross margin, FY2024: 80.28%Gross margin, FY2025: 8.66%Operating margin, FY2021: 36.33%Operating margin, FY2022: 34.67%Operating margin, FY2023: 22.24%Operating margin, FY2024: 17.37%Operating margin, FY2025: 16.72%Net margin, FY2021: 24.83%Net margin, FY2022: 22.54%Net margin, FY2023: 6.84%Net margin, FY2024: -2.75%Net margin, FY2025: 4.21%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 83.27%. Gross margin FY2022 82.97%. Gross margin FY2023 81.64%. Gross margin FY2024 80.28%. Gross margin FY2025 8.66%. Operating margin FY2021 36.33%. Operating margin FY2022 34.67%. Operating margin FY2023 22.24%. Operating margin FY2024 17.37%. Operating margin FY2025 16.72%. Net margin FY2021 24.83%. Net margin FY2022 22.54%. Net margin FY2023 6.84%. Net margin FY2024 -2.75%. Net margin FY2025 4.21%.

Income trends

Revenue

121.2M USD+4.67%

Operating income

20.27M USD+0.75%

Net income

5.1M USD+8.28M USD
Income trends across reported periods133.63M USD83.88M USD34.13M USD−15.62M USDRevenue, FY2021: 90.58M USDRevenue, FY2022: 97.68M USDRevenue, FY2023: 112.85M USDRevenue, FY2024: 115.79M USDRevenue, FY2025: 121.2M USDOperating income, FY2021: 32.91M USDOperating income, FY2022: 33.87M USDOperating income, FY2023: 25.1M USDOperating income, FY2024: 20.12M USDOperating income, FY2025: 20.27M USDNet income, FY2021: 22.49M USDNet income, FY2022: 22.02M USDNet income, FY2023: 7.71M USDNet income, FY2024: −3.18M USDNet income, FY2025: 5.1M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 90.58M USD. Revenue FY2022 97.68M USD. Revenue FY2023 112.85M USD. Revenue FY2024 115.79M USD. Revenue FY2025 121.2M USD. Operating income FY2021 32.91M USD. Operating income FY2022 33.87M USD. Operating income FY2023 25.1M USD. Operating income FY2024 20.12M USD. Operating income FY2025 20.27M USD. Net income FY2021 22.49M USD. Net income FY2022 22.02M USD. Net income FY2023 7.71M USD. Net income FY2024 −3.18M USD. Net income FY2025 5.1M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue121.2M USD115.79M USD112.85M USD97.68M USD90.58M USD
Cost of goods sold110.7M USD22.83M USD20.71M USD16.64M USD15.16M USD
Gross profit10.5M USD92.95M USD92.13M USD81.04M USD75.42M USD
Selling, general, and administrative25.1M USD19.06M USD27.34M USD14.84M USD12.11M USD
Operating expenses−9.77M USD72.84M USD67.03M USD47.18M USD42.51M USD
Interest income−156K USD530K USD813K USD66K USD57K USD
Interest expense34.05M USD23.71M USD17.79M USD11.87M USD10.54M USD
Depreciation and amortization43.54M USD43.71M USD40.44M USD33.19M USD31.23M USD
Operating income20.27M USD20.12M USD25.1M USD33.87M USD32.91M USD
Net income5.1M USD−3.18M USD7.71M USD22.02M USD22.49M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
0.077
FY2025
Latest fiscal-year revenue
121.2M USD
FY2025 · +4.67% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.980.540.1-0.34FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend124.26M112.01M99.76M87.52MFY21FY22FY23FY24FY25

CHCT news

CHCT peers

ETFs holding CHCT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CHCT

research.disclaimer